Veracyte (VCYT) to Acquire Decipher Biosciences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500, Nasdaq set for steep weekly losses as AI jitters rattle investors
- Oil prices gain more than 3%, heading for weekly gain with focus on Middle East supply
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Vertiv shares fall on analyst downgrades and options bets
- Stocks edge lower as dollar heads for weekly loss
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
Veracyte to Acquire Decipher Biosciences
February 3, 2021 7:05 AM ESTFurther solidifies global leadership in differentiated, genomics-driven cancer diagnostics
Expands TAM with presence in 7 of the 10 most common cancers
Expected to accelerate revenue growth
Tina Nova, Ph.D., Decipher Biosciences president and CEO, has left Veracytes board and will become Veracytes GM, urologic cancers
Investor conference call and webcast today at 8:00 a.m. Eastern Time
SOUTH SAN FRANCISCO, Calif., & SAN DIEGO, Calif.--(BUSINESS... More



